← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 2008-02-27

Drug application

FDA Application #

ANDA077260

Application type

Abbreviated New Drug Application (Generic)

Brand name

IRINOTECAN HYDROCHLORIDE

Generic name

Irinotecan Hydrochloride

Active ingredients

IRINOTECAN HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

TEVA PARENTERAL

First approval

2008-02-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown